Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy

Assessing the Beneficial Impact of a Patient Support Program in Secukinumab-Treated Patients with Psoriasis in Italy

Giuseppe Argenziano,1,* Paolo Amerio,2 Maria Grazia Aragone,3 Ginevra Baggini,4 Manuela Baldari,5 Gianpiero Castelli,6 Simmaco Coppola,7 Antonio Costanzo,8,9 Rocco De Pasquale,10 Maria Concetta Fargnoli,11 Caterina Foti,12 Claudia Giofrè,13 Serena Lembo,14 Claudia Leporati,15,16 Francesco...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Argenziano G, Amerio P, Aragone MG, Baggini G, Baldari M, Castelli G, Coppola S, Costanzo A, De Pasquale R, Fargnoli MC, Foti C, Giofrè C, Lembo S, Leporati C, Loconsole F, Malara G, Peris K, Richetta AG, Savoia P, Tiberio R, Travaglini M, Uzzauto MT, Bianchi L
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
dermatology
psolife care program
quality of life
treatment adherence
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/c4a24d587ebb4a109ffacd9b7187f80d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/c4a24d587ebb4a109ffacd9b7187f80d

Ejemplares similares